Opko Health is a healthcare company. Co.'s reportable segments are: diagnostics, which consists of the clinical laboratory operations of its subsidiary, BioReference Laboratories, Inc. (BioReference), as well as its point-of-care operations; and pharmaceutical, which consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Through BioReference, Co. provides laboratory testing services in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare. The OPK stock yearly return is shown above.
The yearly return on the OPK stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the OPK annual return calculation with any dividends reinvested as applicable (on ex-dates).
|